JeffreyArthurTiceMD
Internal Medicine • San Francisco, CADivision of General Internal Medicine at UCSF
Dr. Tice is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1701 Divisadero Street
San Francisco, CA 94143Phone+1 415-353-7300Fax+1 415-353-7901
Summary
- Dr. Jeffrey Tice is an internist in San Francisco, CA and is affiliated with multiple hospitals in the area, including UCSF Medical Center and Zuckerberg San Francisco General Hospital and Trauma Center. He received his medical degree from University of California San Francisco School of Medicine and has been in practice 23 years. He also speaks multiple languages, including French. He is experienced in menopause, medical genetics, evidence-based medicine, biomedical technology assessment, and breast cancer risk assessment.
Education & Training
University of California (San Francisco)Residency, Internal Medicine, 1994 - 1997- University of California San Francisco School of MedicineClass of 1994
Certifications & Licensure
CA State Medical License 1996 - 2026- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Evaluating the Cost-Effectiveness of Etranacogene Dezaparvovec Gene Therapy for Hemophilia B Treatment in the USA.Jyotirmoy Sarker, Jeffrey A Tice, David M Rind, Surrey M Walton
Applied Health Economics and Health Policy. 2024-12-02 - A network meta-analysis of KarXT and commonly used pharmacological interventions for schizophrenia.Abigail C Wright, Avery McKenna, Jeffrey A Tice, David M Rind, Foluso Agboola
Schizophrenia Research. 2024-12-01 - Imetelstat for anemia in lower-risk myelodysplastic syndromes: A summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum.Shahariar Mohammed Fahim, Jeffrey A Tice, Linda Luu, Josh J Carlson, Marina Richardson
Journal of Managed Care & Specialty Pharmacy. 2024-12-01
Press Mentions
Starting Mammograms at Age 40: Will Women Benefit?October 30th, 2024- Gene Therapy for Hemophilia B and an Update on Gene Therapy for Hemophilia A:November 2nd, 2022
- Nonpharmacologic and Pharmacologic Management of Acute Pain from Non–Low Back, Musculoskeletal Injuries in Adults: A Clinical Guideline from the American College of Physicians and American Academy of Family PhysiciansAugust 18th, 2020
- Join now to see all
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
